Beyond Medical Technologies Stock Probability Of Bankruptcy
| DOCKF Stock | USD 0.02 0 22.70% |
Beyond | Probability Of Bankruptcy |
Beyond Medical Technologies Company chance of financial distress Analysis
Beyond Medical's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Beyond Medical Probability Of Bankruptcy | Over 87% |
Most of Beyond Medical's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beyond Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Beyond Medical probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Beyond Medical odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Beyond Medical Technologies financial health.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share (0) | Quarterly Revenue Growth (0.92) | Return On Assets (2.19) | Return On Equity (1.89) |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Beyond Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for Beyond Medical is extremely important. It helps to project a fair market value of Beyond Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Beyond Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Beyond Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Beyond Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Beyond Medical Technologies has a Probability Of Bankruptcy of 87%. This is 104.32% higher than that of the Machinery sector and 78.46% higher than that of the Industrials industry. The probability of bankruptcy for all United States stocks is 118.43% lower than that of the firm.
Beyond Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beyond Medical's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beyond Medical could also be used in its relative valuation, which is a method of valuing Beyond Medical by comparing valuation metrics of similar companies.Beyond Medical is currently under evaluation in probability of bankruptcy category among its peers.
Beyond Medical Main Bankruptcy Drivers
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Return On Assets | (2.06) | (5.95) | (1.29) | (2.3) | (6.23) | (5.92) | |
| Total Current Liabilities | 146.8K | 274.3K | 413.3K | 346.9K | 430.4K | 332.3K | |
| Total Assets | 3.8M | 1.8M | 2.0M | 608.2K | 95.6K | 90.9K | |
| Total Current Assets | 3.4M | 1.2M | 1.8M | 579.3K | 95.6K | 90.9K | |
| Total Cash From Operating Activities | (2.4M) | (1.8M) | (1.4M) | (947.3K) | (527.0K) | (553.4K) |
Beyond Fundamentals
| Return On Equity | -1.89 | ||||
| Return On Asset | -2.19 | ||||
| Current Valuation | 202.38 K | ||||
| Shares Outstanding | 7.91 M | ||||
| Shares Owned By Insiders | 5.57 % | ||||
| Price To Earning | 38.84 X | ||||
| Price To Book | 17.94 X | ||||
| Price To Sales | 1.41 X | ||||
| Gross Profit | (250.49 K) | ||||
| EBITDA | (773.19 K) | ||||
| Net Income | (595.96 K) | ||||
| Cash And Equivalents | 877.31 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 30 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.73 X | ||||
| Book Value Per Share | (0.06) X | ||||
| Cash Flow From Operations | (527.04 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 27.98 | ||||
| Beta | 6208.78 | ||||
| Market Capitalization | 168.38 K | ||||
| Total Asset | 95.64 K | ||||
| Retained Earnings | (26.1 M) | ||||
| Working Capital | (334.72 K) | ||||
| Net Asset | 95.64 K |
About Beyond Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beyond Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:Check out Beyond Medical Piotroski F Score and Beyond Medical Altman Z Score analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share (0) | Quarterly Revenue Growth (0.92) | Return On Assets (2.19) | Return On Equity (1.89) |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.